Table 1.

Layer-specific PC counts in the experimental specimens.

PC Numbers
Treatment	Position	Mean	SD	Dev. from Control (%)	N
C	DL	38.375	3.114		8
	IL	28.375	4.502		8
	SL	26.125	3.980		8
IP	DL	33.000	1.732	−14.01	3
	IL	23.667	2.082	−16.59	3
	SL	21.667	1.528	−17.07	3
IV	DL	33.714	4.572	−12.15	7
	IL	27.857	5.669	−1.83	7
	SL	22.286	5.251	−14.70	7

C: sham-treated control, IP: intraperitoneally and IV: intravitreally imatinib-treated.